The enteric pathogens enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli employ a type 3 secretion system (T3SS) to manipulate the host inflammatory response during infection. Previously, it has been reported that EPEC, in a T3SSdependent manner, induces an early proinflammatory response through activation of NF-B via extracellular signal-regulated kinases 1 and 2 (ERK1/2) and protein kinase C (PKC). However, the activation of NF-B during infection has not yet been attributed to an effector. At later time points postinfection, NF-B signaling is inhibited through the translocation of multiple effectors, including NleE and NleC. Here we report that the highly conserved non-LEE (locus of enterocyte effacement)-encoded effector F (NleF) shows both diffuse and mitochondrial localization during ectopic expression. Moreover, NleF induces the nuclear translocation of NF-B p65 and the expression of interleukin 8 (IL-8) following ectopic expression and during EPEC infection. Furthermore, the proinflammatory activity and localization of NleF were dependent on the C-terminal amino acids LQCG. While the C-terminal domain of NleF has previously been shown to be essential for interaction with caspase-4, caspase-8, and caspase-9, the proinflammatory activity of NleF was independent of interaction with caspase-4, -8, or -9. In conclusion, EPEC, through the T3SS-dependent translocation of NleF, induces a proinflammatory response in an NF-B-dependent manner in the early stages of infection.
way by EPEC during the infection of epithelial cells has not yet been attributed to an effector.
The non-LEE-encoded effector F (NleF) (18, 19 ) is highly conserved among EPEC and EHEC strains (20) . NleF can inhibit the proteolytic activity of the inflammatory caspases caspase-4 and caspase-8, as well as the activity of caspase-9 (21) . The 4 C-terminal amino acids of NleF, with the motif LQCG, are essential for this interaction (21) . Furthermore, Olsen and colleagues have identified TMP21, a type 1 transmembrane protein involved in vesicular transport, as a binding partner of NleF (22) . The aim of this study was to further characterize the biological activity of NleF.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and reagents. The E. coli strains used in this study are listed in Table 1 . E. coli was cultured in Luria broth (LB) at 37°C and 200 rpm with the appropriate antibiotics: 100 g/ml ampicillin and 50 g/ml kanamycin. All reagents were purchased from Sigma-Aldrich unless otherwise stated.
Tissue culture. HeLa cells were grown in Dulbecco's modified Eagle's medium-low glucose (DMEM; 1,000 mg/liter) supplemented with 10% (vol/vol) heat-inactivated fetal calf serum (FCS; Gibco), 2 mM GlutaMAX (Invitrogen), and 0.1 mM nonessential amino acids under a 5% CO 2 atmosphere.
Plasmid construction. The plasmids and primers used in this study can be found in Tables 1 and 2, respectively. nleF was amplified from E. coli O127:H6 E2348/69 genomic DNA by PCR using KOD Hot Start polymerase (Novagen). nleF and nleF were cloned into the mammalian expression vector pRK5::myc following amplification with primer pairs 1F/1R and 1F/2R, respectively. PCR products were cloned into the BamHI/PstI sites of pRK5::myc to generate plasmids pICC1661 and pICC1667, respectively. Alternatively, nleF was cloned into pEGFP-C2 following amplification with primer pair 7F/7R using the EcoRI/BamHI restriction sites to generate pICC1675. nleF was cloned into the EcoRI/ HindIII sites of pBAD22 using primer pair 6F/6R to construct plasmid pICC1662. Plasmids were codon optimized to remove a polythyminerich region by using primer pair InvF/InvR. All constructs were verified by DNA sequencing.
Mutant construction. nleF was deleted from EPEC E2348/69 by using the lambda Red system (23) , generating strain ICC1082. Primer pair pKD4F/pKD4R was used to amplify the kanamycin cassette from pKD4. Primer pair 3F/3R was used to amplify nleF from Escherichia coli O127:H6 E2348/69 genomic DNA with 500-bp 5= and 400-bp 3= flanking sequences. The PCR product was cloned into TOPO Blunt II (Invitrogen) by blunt-end ligation. nleF was removed by inverse PCR with primer pair 4F/4R and was replaced with the kanamycin cassette using blunt-end ligation to construct plasmid pICC1674. The linear product for recombination was amplified from pICC1674 using primer pair 3F/3R, and mutagenesis was confirmed by sequencing using primer pair 5F/5R. Transfection and siRNA. HeLa cells were grown until ϳ40% confluent in 24-well plates containing 13-mm glass coverslips (VWR International). Sixteen hours postseeding, monolayers were transfected with the mammalian expression vectors listed in Table 1 by using the GeneJuice kit (Novagen/Merck) according to the manufacturer's specifications. Transfected cells were left for 24 h and, where indicated, were stimulated with TNF at 20 ng/ml for 30 min for immunofluorescence or for 16 h for reverse transcription-quantitative PCR (RT-qPCR) before being washed 3 times in phosphate-buffered saline (PBS). Plates were stored at Ϫ80°C for RT-qPCR or were fixed for immunofluorescence as described below. For knockdown, ON-TARGETplus SMARTpool scrambled small interfering RNA (siRNA) (D-001810-10-05), caspase-4 siRNA (L-004404-00-0005), caspase-8 siRNA (L-003466-00-0005), and caspase-9 siRNA (L-003309-00-0005) (Dharmacon) were transfected at 20 nM using HiPerFect transfection reagent (Qiagen) according to the manufacturer's instructions. Knockdown efficiency was analyzed by RT-qPCR and Western blotting as described below.
Isolation of mRNA and RT-qPCR. Cells were washed in PBS, and mRNA was isolated (with an RNeasy minikit) according to the manufacturer's instructions (Qiagen). Samples were treated with RQ1 DNase-I (Promega) at 37°C for 30 min, followed by 15 min at 72°C. Reverse transcription-PCR was carried out according to the manufacturer's instructions (Promega) with the following adaptations. RNasin (Promega) was added to the reaction buffer at 2 to 4 U/l. IL-8, caspase-4, caspase-8, caspase-9, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs were amplified with primer pairs IL-8F/IL-8R, CASP4F/CASP4R, CASP8F/CASP8R, CASP9F/CASP9R, and GAPDHF/GAPDHR, respectively, by RT-qPCR using the 7300 real-time PCR system (Applied Biosystems) under standard cycle conditions. Changes in gene expression levels were analyzed relative to the control levels (see figure legends for individual experiments), with GADPH as a standard, using the ⌬⌬C T method.
Infection assay. HeLa cells were washed three times with PBS 3 h prior to infection, and the medium was replaced with DMEM with no additives. Bacterial strains grown overnight for 17 h in LB were diluted 1:100 and were primed in DMEM supplemented with 100 g/ml ampicillin for complemented strains only for 3 h at 37°C under a 5% CO 2 atmosphere without agitation. Arabinose or isopropyl-␤-D-thiogalactopyranoside (IPTG) was added at 1 mM or 0.5 mM to ⌬nleF pnleF or ⌬PP4/IE6 pnleE bacterial cultures, respectively, 0.5 h before infection. After 3 h of priming, the medium was removed from the HeLa cells and was replaced with 0.5 ml of a 1:3 dilution of primed bacterial culture in DMEM. The infection was carried out for 1.5 h and 4 h, and where indicated, cells were treated with 20 ng/ml of TNF for 30 min after 3.5 h of infection. For the 1.5-h or 4-h time point, cells were washed 3 times with PBS 1 h postinfection and were incubated for a further 0.5 h or 3 h. Cells were washed 3 times in PBS and were either fixed for immunofluorescence or lysed for Western blot analysis as described below. Immunofluorescence staining and antibodies. For immunofluorescence staining, cells were fixed with 3% paraformaldehyde and were washed another 3 times in PBS before being quenched in 50 mM NH 4 Cl, permeabilized with 0.2% Triton-X 100, and washed 3 times in PBS. Coverslips were blocked in 1% bovine serum albumin (BSA)-PBS. All antibodies, unless stated otherwise, were diluted directly in 1% BSA-PBS. Primary antibodies were incubated for 45 min, followed by incubation of the secondary antibodies and reagents for 30 min. Mouse monoclonal antibodies against Myc (clone 4A6; product no. 05-724; Millipore), caspase-4 (clone 4B9; catalog no. sc-56056; Santa Cruz), fluorescein isothiocyanate (FITC)-conjugated Myc (clone 9E10; product no. F2047; Sigma-Aldrich), alpha-tubulin (clone DM1A; product no. T6199; Sigma-Aldrich), and TOMM22 (ab57523; Abcam) and rabbit polyclonal antibodies against N-terminal NF-B p65 (clone A; catalog no. sc-109; Santa Cruz) and IB␣ (antibody 2942; Cell Signaling) were used as primary antibodies. DyLight 488-conjugated donkey anti-mouse IgG(HϩL) (catalog no. 715-485-150; Jackson ImmunoResearch) was used as a secondary antibody for immunofluorescence, and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (catalog no. 115-035-008; Jackson ImmunoResearch) and HRP-conjugated goat anti-rabbit IgG (catalog no. 111-035-008; Jackson ImmunoResearch) were used as secondary antibodies for Western blot analysis. 4=,6-Diamidino-2-phenylindole (DAPI) was used to visualize the nucleus. Coverslips were then mounted using ProLong Gold Antifade reagent (Invitrogen) before visualization on a Zeiss Axio Imager immunofluorescence microscope using Zeiss Axio-Vision software, release 4.5.
Western blotting. Ninety minutes postinfection, cells were lysed in loading dye (lithium dodecyl sulfate [LDS], 250 mM Tris [pH 6.8], 40% glycerol, 6% SDS, 1% bromophenol blue, and 0.8% ␤-mercaptoethanol), boiled for 10 min, run on an SDS-PAGE gel, and then transferred to a polyvinylidene difluoride (PVDF) membrane. The membranes were blocked in Tris-buffered saline (10 mM Tris, 150 mM NaCl [pH 7.4])-0.1% Tween (TBS-T) containing 5% semiskimmed milk (blocking buffer) for 1 h before incubation with the primary antibody in blocking buffer for 16 h at 4°C. The membrane was washed in TBS-T, and the secondary antibody was incubated for 2 h in blocking buffer. Western blots were visualized by the addition of ECL solution (GE Healthcare) and were developed by the LAS-3000 imager (Fuji). Densitometry was analyzed using ImageJ.
Luciferase assay. An NF-B dual-luciferase reporter system (Promega) was employed as described previously (15) , with the following adaptations. HeLa cells were seeded as described above and were cotransfected with pEGFP-C2 or pEGFP-nleF together with pNF-B-Luc (Clontech) and pRL-TK (Promega). Twenty-four hours posttransfection, for each condition, the expression of firefly luciferase was measured and was normalized to Renilla luciferase expression, and NF-B activity was expressed relative to that in HeLa cells transfected with pEGFP (HeLa-pEGFP).
Statistics. All data were analyzed with GraphPad Prism software, using one-way analysis of variance (ANOVA) and Bonferroni's multiplecomparison test when required. A P value of Ͻ0.05 was considered statistically significant.
RESULTS

NleF is localized to the mitochondria. Previous studies have
shown that a C-terminally tagged NleF protein has a diffuse cytoplasmic localization in the COS-7 cell line (19) . In this study, we transfected HeLa cells with the mammalian expression vector pRK5::myc-nleF (HeLa-NleF) and analyzed the localization of an N-terminally tagged NleF protein 16, 24, and 48 h later by immunofluorescence staining. At 16 h and 24 h posttransfection, NleF BamHI  1R  TGCACTGCAGATCATCCACATTGTAAAGATCCTTTG  PstI  2R  CTGCACTGCAGTTAAGATCCTTTGTTGTAAGTAAGAT  PstI  InvF  TTCCTGCATTCATTGAAAGTAAAAATTGAGG  InvR  GAACAGATCCCTGATATAACTATCCCTAT  3F  GATATGGAAGATACAACAAAAGTGTT  3R  ACAGAAGAGGCAGGCCAGCA  4F  TTAGAGGCCTGTGAGCCTGT  4R  ATCAAAACCCCCTTAACAAATAAATC  pKD4F  TGTGTAGGCTGGAGCTGCTTC  pKD4R  CATATGAATATCCTCCTTAGTTCC  5F GTAAAGGTGGTAATGCTGTCGT
ACAGCCGTGAGAGAGAAT either was diffusely localized or exhibited a punctate perinuclear localization ( Fig. 1A and C; data shown for 24-h time point). Expression of NleF after 48 h was cytotoxic; therefore, localization could not be analyzed (data not shown). In control HeLa cells transfected with pRK5::myc-GFP (HeLa-GFP), Myc-GFP exhibited exclusively diffuse staining ( Fig. 1A) . To further establish the subcellular localization of NleF, cells were costained for the major organelles, including the Golgi apparatus (GM130), endoplasmic reticulum (ER) (calnexin), and mitochondria (TOMM22). While there was no apparent colocalization of NleF with either the Golgi apparatus or the ER at 24 h (data not shown), perinuclear NleF colocalized with the mitochondrial outer membrane protein TOMM22 (Fig. 1A) .
The C terminus of NleF is required to bind caspase-4, -8, and -9 (21) . To determine if the mitochondrial localization of NleF is dependent on its C terminus, we deleted the four C-terminal amino acids LQCG (NleF 1-185 ). HeLa cells transfected with Myctagged NleF 1-185 (HeLa-NleF 1-185 ) revealed no colocalization with TOMM22 ( Fig. 1B) , indicating an essential role of the C terminus in the mitochondrial targeting of NleF.
Ectopic expression of NleF triggers nuclear translocation of NF-B p65. While caspases are commonly known for their role in apoptosis, both caspase-8 and caspase-4 have a dual function in that they also regulate NF-B signaling (24, 25) . To investigate if NleF had a role in NF-B activation, we determined the localization of p65 in HeLa-NleF cells. Cells exposed to TNF or ectopically expressing the T3SS effector NleE (HeLa-NleE) or HeLa-GFP were used as controls. Expression of NleF alone was sufficient to stimulate the nuclear translocation of p65, suggesting that NleF can activate the NF-B pathway ( Fig. 2A and B) . The number of cells exhibiting nuclear translocation of p65 in HeLa-NleF was significantly higher than that for the HeLa-GFP control: 71.97% of HeLa-NleF exhibited nuclear localization of p65, in contrast to 1.04% of HeLa-GFP (Fig. 2B) . As described previously (15) , NleE successfully inhibited NF-B activation, with only 15.10% of NleE-expressing cells exhibiting nuclear translocation of p65 when stimulated with TNF, in contrast to the TNF-treated control at 99.86% ( Fig. 2A and B) . The translocation of p65 to the nucleus was dependent on the LQCG motif of NleF, with only 9.67% of HeLa-NleF 1-185 displaying nuclear p65 ( Fig. 2A and B) . The activity of NleF was independent of its subcellular localization: both diffusely localized NleF and mitochondrially localized NleF were able to activate p65 nuclear translocation significantly ( Fig. 3A and B) . This in- dicated that NleF can activate the translocation of NF-B p65 and that this translocation is dependent on its C-terminal domain.
NleF upregulates IL-8 expression. Nuclear translocation of p65 subsequently leads to the expression of genes under the regulation of NF-B. In order to confirm that NleF-induced NF-B p65 translocation leads to transcriptional activation, a dual-luciferase reporter assay was used. HeLa cells transfected with the luciferase reporter plasmid (HeLa-NF-B) and further transfected with pEGFP-nleF (HeLa-GFP-NleF) were compared to HeLa-NF-B transfected with pEGFP (HeLa-pEGFP). HeLa-GFP-NleF were able to activate the NF-B-dependent promoter significantly, with a 2-fold increase in luciferase activity over that of the HeLa-pEGFP control (Fig. 2C) .
Because NleF activated the nuclear translocation of p65 and upregulated an NF-B-dependent reporter, we analyzed IL-8 mRNA levels in HeLa-NleF by RT-qPCR. TNF-stimulated cells were used as a positive control. As shown in Fig. 4A , IL-8 mRNA levels were significantly higher in TNF-stimulated cells (11-fold) or in HeLa-NleF (5.8-fold) than in HeLa-GFP (Fig. 4A ). This increase in IL-8 expression was dependent on the C terminus of NleF; no significant change in IL-8 expression levels was seen for HeLa-NleF 1-185 in comparison to HeLa-GFP (Fig. 4A) .
Importantly, similar levels of NleF and NleF 1-185 were detected by Western blotting, confirming that the lack of activity was not due to a loss of integrity of NleF 1-185 or to a difference in expression levels (Fig. 4B ).
NleF-induced upregulation of IL-8 expression is independent of caspase-4, -8, and -9.
In addition to its role in NF-B activation, the C terminus of NleF is essential for binding caspase-9, -4, and -8, of which the latter two are involved in inflammatory signaling (24, 25) . To determine if caspase-4, -8, or -9 has a role in NleF-induced NF-B activation, their expression in HeLa cells was knocked down by specific siRNAs. Scrambled siRNA was used as a negative control. siRNA-transfected HeLa cells were then transfected with pRK5-myc-gfp or pRK5::myc-nleF. Caspase knockdown and NF-B activation were verified by RT-qPCR. Transfection with siRNA successfully knocked down the expression of caspase-4, -8, and -9 to 11%, 18%, and 10% of the levels for the scrambled-siRNA-transfected controls, respectively ( Fig. 5A to C) . Knockdown of caspase-4 was further verified by Western blotting (Fig. 5E ). HeLa cells transfected with scrambled siRNA and pRK5-myc-nleF exhibited IL-8 mRNA levels 4-foldhigher than those of cells transfected with scrambled siRNA and pRK5-myc-gfp (Fig. 5D ). Knockdown of caspase-4, -8, or -9 did not significantly alter the NleF-dependent upregulation of IL-8 expression relative to IL-8 expression with GFP ( Fig. 5D ). Furthermore, double knockdown of caspase-4 and -8 had no effect on the NleF-dependent upregulation of IL-8 expression (data not shown).
NleF is essential for early activation of the NF-B pathway during infection. In order to determine if NleF also activates NF-B during infection, HeLa cells were infected for 1.5 h and/or 4 h with wild-type (WT) EPEC, EPEC ⌬escN, EPEC ⌬nleF, EPEC ⌬nleF complemented with full-length NleF (⌬nleF pnleF), EPEC ⌬PP4/IE6, or EPEC ⌬PP4/IE6 complemented with NleE (⌬PP4/ IE6 pnleE) and were then analyzed for p65 localization by immunofluorescence staining. As a control for NF-B inhibition and activation, HeLa cells infected with WT EPEC or uninfected cells were treated with TNF for 30 min prior to the 4-h time point. At 1.5 h postinfection, 46% of cells infected with WT EPEC exhibited a nuclear localization for p65 compared to 0.54% of cells infected with EPEC ⌬escN, suggesting that EPEC can activate NF-B translocation early in infection in a T3SS-dependent manner ( Fig. 6A and B ). Furthermore, deletion of nleF alone was sufficient to abrogate the activation of NF-B by EPEC infection at 1.5 h ( Fig. 6A and B ). This activation was partially restored upon complementation of the ⌬nleF strain with full-length nleF: 24% of cells infected with the complemented strain exhibited nuclear p65, in contrast to 3.6% of cells infected with EPEC ⌬nleF (Fig. 6A and B) .
At 4 h postinfection, as previously reported (15), NF-B was excluded from the nucleus, with no statistical difference between uninfected cells and cells infected with either the WT EPEC, EPEC ⌬escN, or EPEC ⌬nleF strain ( Fig. 7A and B ). Cells infected with WT EPEC, as expected, inhibited TNF-stimulated nuclear translocation of NF-B p65, in contrast to uninfected TNF-treated cells, with 6.2% and 97% of cells exhibiting nuclear p65, respectively ( Fig. 7B ). Furthermore, cells infected with EPEC ⌬PP4/IE6, which lacks the anti-inflammatory effector genes but contains nleF, were able to activate NF-B nuclear translocation significantly (92%) even at 4 h postinfection (Fig. 7B) . The activation of NF-B p65 nuclear translocation by EPEC ⌬PP4/IE6 could be significantly decreased, to 11.6% of cells, by complementation with NleE alone (Fig. 7B) .
To further verify the role of NleF in NF-B activation during infection, IL-8 mRNA levels were analyzed by RT-qPCR 1.5 h postinfection. While infection with EPEC ⌬escN induced only a 2.3-fold increase in IL-8 expression, infection with WT EPEC increased IL-8 expression significantly, 28.5-fold over expression by the uninfected control (Fig. 6C) . Importantly, deletion of nleF alone decreased the induction of IL-8 expression from that with WT EPEC infection; this induction was partially restored upon complementation of the ⌬nleF mutation ( Fig. 6C) .
Degradation of IB␣ is an integral step in the activation of the NF-B pathway. To determine if there were changes in cellular IB␣ levels 1.5 h postinfection, cells infected with WT EPEC, EPEC ⌬nleF, or EPEC ⌬nleF pnleF were analyzed by immunoblotting. Upon infection with WT EPEC, IB␣ levels were markedly decreased from those in uninfected cells and in cells infected with EPEC ⌬nleF, while complementation with EPEC ⌬nleF pnleF partially restored the degradation of IB␣ (Fig. 6D) . Taken together, these results suggest that NleF translocation leads to IB␣ degra-dation, p65 nuclear translocation, and transcriptional activation of IL-8 during EPEC infection.
DISCUSSION
Through the secretion of a plethora of T3SS effectors, EPEC manipulates host cell functions, including the host immune responses, aiding bacterial colonization and survival. Several T3SS effectors have been reported to exhibit anti-inflammatory activity during infection; these include NleC (11, 12) and NleD (26) , which degrade p65 and p38, respectively, and NleE, which prevents IK phosphorylation (13) (14) (15) . In this paper, we have shown that during the early stages of infection, NleF exhibits proinflammatory activity.
Blasche and colleagues have reported previously that NleF binds caspase-4, -8, and -9 (21) . Both caspase-8 and caspase-4 can regulate the NF-B signaling pathway (23, 24) . Here we observed that ectopic expression of NleF resulted in nuclear translocation of focus of many studies. The concept that EPEC translocates proinflammatory effectors has been postulated previously; early in infection, EPEC upregulates proinflammatory signaling through protein kinase C (PKC), the mitogen-activated protein (MAP) kinases extracellular signal-regulated kinases 1 and 2 (ERK1/2) (27) (28) (29) , and the NF-B pathway (15, 30) , all in a T3SS-dependent manner. Here we report that early in infection, WT EPEC induced a T3SS-dependent proinflammatory response through NF-B activation, resulting in the nuclear translocation of p65 and the expression of IL-8. Previous studies have identified an arsenal of effectors that are employed by EPEC to inhibit the activation of NF-B during infection. The extent to which EPEC and other A/E pathogens prevent activation of this pathway with a multieffector approach indicates that suppression of the inflammatory response is critical to the infection strategy. Conversely, the inflammatory response is infected with the EPEC WT, ⌬escN, ⌬nleF, ⌬PP4/IE6, or ⌬PP4/IE6 pnleE strain for 4 h. Cells either were left unstimulated or were stimulated with 20 ng/ml TNF for 30 min, as indicated. Cell nuclei were visualized with DAPI. Bars, 10 m. (B) Counts were taken in 8 separate fields of view for each condition of cells exhibiting nuclear p65. There was a difference in p65 nuclear translocation between uninfected, unstimulated (Un) cells and uninfected, TNF-stimulated (Un ϩ TNF␣) cells and between Un cells and cells infected with the ⌬PP4/IE6 strain. No significant difference was reported between Un cells and WT-infected, unstimulated cells or between Un cells and WT-infected cells stimulated with TNF, and no difference was reported between WT-infected cells and cells infected with the ⌬nleF or ⌬escN strain. Asterisks indicate significant differences (P Ͻ 0.05) from results for Un cells. Results are averages for 2 independent repeats. associated with colonic crypt hyperplasia as well as with inflammatory cell infiltration of the lamina propria during infection with the EPEC-like mouse pathogen Citrobacter rodentium (31) . This inflammation and colitis early in infection is associated with alterations in the commensal microbiota that supports pathogen growth (32, 33) . This balance may be critical for A/E pathogens, enabling them to outcompete commensal bacteria but limit hostmediated immune clearance.
While the mechanism of the proinflammatory effect of NleF is unknown, we observed that NleF expressed ectopically in HeLa cells colocalized with the mitochondrial outer membrane protein TOMM22. Although NleF was also observed in a diffuse staining pattern in the cytosol in some of the transfected cells, this may result from overexpression and does not rule out the possibility that NleF is still targeting the mitochondria in these cells. Bioinformatic analysis of NleF does not reveal a predicted mitochondrial signal sequence; however, the mitochondrial localization of NleF was dependent on the C terminus. The C-terminal domain of NleF is essential for its interaction with caspase-4, -8, and -9 in vitro, which, as mentioned above, does not facilitate the proinflammatory activity of NleF. It is therefore possible that the mitochondrial localization of NleF and its proinflammatory activity are dependent on interaction with other host partner proteins. A yeast 2-hybrid screen has recently identified mitochondrially localized dihydrofolate reductase as a putative interacting partner of NleF (34) . Moreover, Olsen and colleagues have identified TMP21, which colocalizes with NleF during C. rodentium infection, as an interacting partner of NleF (22) . TMP21 has recently been shown to target PKC-␣, PKC-␦, and PKC-ε (35) , preventing the activity of PKC-␦ by sequestering it in a perinuclear location (35, 36) . While PKCs play integral roles in Toll-like receptor (TLR) signaling and the activation of ERK1/2 and NF-B, TMP21 itself does not colocalize with mitochondrial NleF when coexpressed in HeLa cells (data not shown) (37) (38) (39) (40) .
In summary, this study establishes that EPEC, through the T3SS-dependent translocation of NleF, induces a proinflammatory response in an NF-B-dependent manner in the early stages of infection.
